期刊文献+

椎体成形术应用不同填充材料治疗骨质疏松椎体压缩性骨折的实验研究 被引量:5

Experimental study on the different injectable material in vertebroplasty
下载PDF
导出
摘要 目的通过用不同填充材料对骨质疏松兔的椎体成形,进而对行椎体成形术后椎体的生物力学行动态观察,从而得出相关结论,为临床应用提供理论基础。方法选用5个月龄新西兰纯种雌性兔60只,随机选12只作为正常对照组(A组),剩余的48只使用去势法造成骨质疏松模型后随机分成四组,每组12只。模型对照组(B组);聚甲基丙酸甲酯骨水泥(PMMA)组(C组);自固化磷酸钙骨水泥(瑞邦骨泰,CPC)组(D组);骨形态发生蛋白(BMP)和CPC组(E组)。解剖出椎体后直视下穿刺,按组别分别注入上述填充剂,每只进行3个椎体(L4、L5、L6)。分别于术后当时、8周和16周取椎体标本,行X线检查,并测定不同时间点椎体的轴向抗压强度实验。结果①术后当时拍X线片,除PMMA组有1例可见骨水泥渗漏入椎管内,其余均未见渗漏。术后8周和16周分别拍X线片,可见手术椎体密度较其他椎体和模型对照组椎体均高,与正常对照组相仿。②术后当时C组的抗压强度明显高于其他组(P<0.01),A组抗压强度次之,高于B组(P<0.01)、D组(P<0.01)和E组(P<0.01),而B、D和E组间则差异无统计学意义(P>0.05)。术后8周,C组抗压强度有所下降与术后当时相比差异无统计学意义(P>0.05),D和E组抗压强度有所上升(P<0.01),B组抗压强度明显低于其他组(P<0.01)。术后16周,C组抗压强度持续下降与A、D和E组相比差异无统计学意义(P>0.05),D和E组抗压强度继续上升(P<0.01),B组抗压强度继续下降(P<0.01),与其他各组差异有统计学意义(P<0.01)。结论CPC和CPC/BMP虽然具有较好的生物学性能,并且有较为广阔的应用前景,但在临床实际应用中,尤其在治疗骨质疏松脊柱压缩骨折时,尚不能完全取代PMMA。 Objective To provide the theories clinical for the evidence application by dynamic observing biomechanics changes after vertebroplasty with the different filling materials in experimental osteoporotic rabbit. Methods Sixty New Zealand pure breed female rabbits of 5 months old was divide into five groups (A, B, C, D, E), and each group had 12 rabbits.Group A was normal matched control and osteoporotic model were established by ovariectomy from B to E group.Implanted polymethylmethacrylate (PMMA) into the vertebral body of group C and calcium phosphate cement (CPC) into D group and CPC/BMP (bone morphogenic protein) into E group.Group B was the model matched control.When at 0.8 and 16 weeks old,the vertebral bodies implanted were tested by X ray and axial compressive testing.Results ① Bone cement leaked into vertebral canal in one case of group C after operation . The density of vertebral bodies in group C rabbits were higher than other groups by X ray analysis. ②At once after operation,the ultimate strength of vertebral bodies with implanted PMMA was higher than that others (P〈0.01) and group A was second place (B group P〈0.01,D group P〈0.01 ,E group P〈0.01 ).There were no significant differences in B,D and E groups (P〉0.05).After 8 weeks,the stiffness of group A became low,but have no the differences compare to before (P〉0.05).The stiffness of group D and E became stronger (P〈0.01). There was no significant differences in groups A and E (P〉0.05)and significant differences in groups A and D (P〈0.01).When it came to 16 weeks,the stiffness of group A became lower (P〈0.01) and of group D and E became stronger (P〈0.01).There were no significant differences in A,C,D and E groups (P〉0.05).At the last was group B,there were very significant differences between B and other groups (P〈0.01).Conclusion Although CPC and CPCdBMP have the good biology function,and have the vast and applied foreground,they could't replace the PMMA completely in clinically actually application, particularly at cure osteoporotic verterbral compression fractures.
出处 《中国药物与临床》 CAS 2006年第3期175-178,共4页 Chinese Remedies & Clinics
基金 山西省归国人员基金资助项目(2002024)
关键词 骨质疏松 椎体成形术 生物力学 聚甲基丙烯酸甲酯 磷酸钙骨水泥 骨形态发生蛋白 Osteoporosis Vertebroplasty Biomechanics Polymethylmethacrylate Calcium phosphate cement Bone morphogenic protein
  • 相关文献

参考文献13

  • 1Gold DT.The clinical impact of vertebral fractures:quality of life in women with osteoporosis.Bone,1996,18:S185-S189.
  • 2Jensen ME,Evans AJ,Mathis JM,et al.Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebralbody compression fractures:technical aspects.Am J Neuro Radiol,1997,18:1897-1904.
  • 3Winking M,Stahl JP,Oertel M,et al.Polymethylmethacrylatevertebroplasty:a new and effective method of pain treatment in vertebral compression.Dtsh Med Wochenschr,2003,128 (48):2525-2530.
  • 4Brown DB,Gilula LA,Sehgal M,et al.Treament of chronic symptomatic vertebral compression fractures with percutaneous vertebroplasty.Am J Roentgenol,2004,182 (2):319-322.
  • 5Mori H,Manabe M,Kurachi Y,et al.Osteointegration of dental implants in rabbit bone with low mineral density.J Oral Maxillofac Surg,1997,55:351-355.
  • 6Galibert P,Deramond H,Rosat P,et al.Preliminary note on the treatment of vertebralangioma by percutaneous acrylic vertebroplasty.Neurosurgery,1987,33:166-168.
  • 7杨霞,蔡桂英,魏玲,候静,李炯,郑虎,翁玲玲.去势兔骨质疏松模型建立的初探[J].生物医学工程学杂志,1997,14(4):353-358. 被引量:20
  • 8陈守平,周正炎,陆卫青.去势法兔骨质疏松症模型的建立[J].口腔颌面外科杂志,2001,11(3):221-224. 被引量:20
  • 9Racque Z,Lee G.Proportis of osteoconductive biomaterials:calcium phosphate.Clin Orthop,2002,395:81-98.
  • 10Riley EH,Lane JM,Urist MR,et al.Bone morphogenetic protein-2:biology and appoicatiom.Clin Orthop,1996,327:39-46.

二级参考文献11

  • 1王智兴,夏筠,杨庆铭.成年家兔去卵巢后血清骨钙素及多种磷酸酶的变化[J].上海第二医科大学学报,1996,16(6):427-429. 被引量:4
  • 2[1]Dike NK. The ovariectomized rat model of postmenopausal bone loss[J]. Bone Mineral, 1991, 15:175.
  • 3[2]Fujimoto T, Niimi A, Sawai T, et al. Effects of steroid-induce d osteoporosis on osteointegration of titanium implants[J]. Int J Oral Maxill ofac Impl, 1998, 13:183.
  • 4[3]Newman E, Turner AS, Wark JD. The potential of sheep for the st udy osteopenia: current status and comparison with other animal models[J]. Bo ne, 1995, 16:277s.
  • 5[4]Mori H. Manabe M, Kurachi Y, et al. Osteointegration of dental implants in rabbit bone with low mineral density[J]. J Oral Maxillofac Surg, 1997, 55:351.
  • 6Victor H,骨骼系统的生物力学基础(译),1995年,8页
  • 7翁世芳,骨质疏松研究与防治,1994年,270页
  • 8朱清华,实用动物学,1991年,181页
  • 9干如--,分析化学,1986年,185页
  • 10团体著者,生物化学实验教程,1982年

共引文献33

同被引文献67

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部